kyorin pharmaceutical

Discovery Partners International, Inc. And Kyorin Pharmaceutical Co., Inc. Sign Drug Discovery Agreement

Discovery Partners International, Inc. of San Diego, California and Kyorin Pharmaceutical Co., Ltd. of Tokyo, Japan announced further details surrounding the research collaboration to identify drug candidates for an allergy target. Under the agreement, Discovery Partners International, Inc. has responsibility for assay development and hit identification. Kyorin receives worldwide rights to manufacture and market any Read more about Discovery Partners International, Inc. And Kyorin Pharmaceutical Co., Inc. Sign Drug Discovery Agreement[…]

Discovery Partners Announces Agreement With GSK

Discovery Partners International, Inc. has entered into an agreement with Glaxo SmithKline for the delivery of a next generation IRORI(TM) Combinatorial Chemistry Synthesis Platform. Financial terms of the arrangements were not released. Over the next twelve months, Discovery Partners will deliver the first two next generation X-Kan(TM) Chemistry Synthesis Systems for use in GSK sites Read more about Discovery Partners Announces Agreement With GSK[…]